We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia.
- Authors
Beykaso, Gizachew; Mulu, Andargachew; Giday, Mirutse; Berhe, Nega; Selamu, Markos; Hailu, Dawit; Teklehaymanot, Tilahun
- Abstract
Background: The detection of hepatitis B virus surface antigen (HBsAg) in serum remains the mainstay in diagnosing and screening of hepatitis B virus (HBV) in most developing countries. The absence of HBsAg in the blood may not indicate the absence of circulating HBV and might be infectious. Thus, this study aimed to estimate the burden and its cryptic transmission risks of occult hepatitis B infection (OBI) among HBsAg negative healthy individuals in Southern Ethiopia. Methods: A community-based cross-sectional study was conducted from September 2020 to January 2021. Serum samples were collected and assayed for HBsAg and HBV core antibody (anti-HBc) seromarkers using enzyme-linked immunosorbent assay (ELISA). In anti-HBc positive samples, HBV DNA was detected using real-time polymerase chain reaction (RT-PCR). Data were entered into Epi-Data version 3.1, cleaned, and analyzed using SPSS version 21.0. Descriptive and logistic regression analyses were employed. Statistical significance was decided at p < 0.05. Results: A total of 346 were individuals included in this study; 34 (9.8%) were tested positive for HBsAg. The rest 312 (90.2%) negatively tested were further assayed for anti-HBc, and 115 (36.7%) were found positive implying previous exposure to HBV, and 21 (18.3%) out of 115 anti-HBc positives had HBV DNA signifying OBI. The HBV DNA concentration below 200 IU/mL was 85.7%. A high rate of OBI was observed among individuals who had multiple sexual contacts, a family history of hepatitis, and tattooing. Conclusion: In this study, the prevalence of OBI is high. This indicates the burden of HBV is considerable since screening is exclusively dependent on HBsAg which will not eliminate the possibility of residual cryptic transmission through blood donation, organ transplantation, perinatal transmission, and other contacts. Our results demonstrate that nucleic acid-based testing (NAT) should be an essential part of screening to prevent missing OBI.
- Subjects
ETHIOPIA; HEPATITIS associated antigen; CHRONIC hepatitis B; HEPATITIS B; ENZYME-linked immunosorbent assay; HEPATITIS B virus; LOGISTIC regression analysis
- Publication
Infection & Drug Resistance, 2022, Vol 15, p619
- ISSN
1178-6973
- Publication type
Article
- DOI
10.2147/IDR.S344668